NeoGenomics (NASDAQ:NEO) Given New $18.00 Price Target at Piper Sandler
NeoGenomics (NASDAQ:NEO – Free Report) had its price target decreased by Piper Sandler from $21.00 to $18.00 in a research report released on Wednesday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the medical research company’s stock. NEO has been the subject of several other reports. Needham & Company LLC reduced their target […]
NeoGenomics (NASDAQ:NEO – Free Report) had its price target decreased by Piper Sandler from $21.00 to $18.00 in a research report released on Wednesday morning,Benzinga reports. Piper Sandler currently has an overweight rating on the medical research company’s stock. NEO has been the subject of several other reports. Needham & Company LLC reduced their target […]
